Literature DB >> 28074002

Metabolic Profiling in Formalin-Fixed and Paraffin-Embedded Prostate Cancer Tissues.

Stefano Cacciatore1,2, Giorgia Zadra1,3, Clyde Bango1, Kathryn L Penney4,5, Svitlana Tyekucheva6,7, Oscar Yanes8,9, Massimo Loda10,3,11,12.   

Abstract

Metabolite profiling has significantly contributed to a deeper understanding of the biochemical metabolic networks and pathways in cancer cells. Metabolomics-based biomarker discovery would greatly benefit from the ability to interrogate retrospective annotated clinical specimens archived as formalin-fixed, paraffin-embedded (FFPE) material. Mass spectrometry-based metabolomic analysis was performed in matched frozen and FFPE human prostate cancers as well as isogenic prostate cancer cell lines. A total of 352 and 460 metabolites were profiled in human tissues and cell lines, respectively. Classes and physical-chemical characteristics of the metabolites preserved in FFPE material were characterized and related to their preservation or loss following fixation and embedding. Metabolite classes were differentially preserved in archival FFPE tissues, regardless of the age of the block, compared with matched frozen specimen, ranging from maximal preservation of fatty acids (78%) to loss of the majority of peptides and steroids. Generally, FFPE samples showed a decrease of metabolites with functional groups, such as carboxamide. As an adjunct technique, metabolic profiles were also obtained in situ from FFPE tissue sections where metabolites were extracted in a manner that preserves tissue architecture. Despite the fact that selected metabolites were not retained after processing, global metabolic profiles obtained from FFPE can be used to predict biologic states and study biologic pathways. These results pave the way for metabolomics-based biomarker discovery/validation utilizing retrospective and clinically annotated FFPE collections.Implications: Metabolic profiles can be performed in archival tissue and may be used to complement other profiling methods such as gene expression for biomarker discovery or pathway analysis in the assessment of biologic states. Mol Cancer Res; 15(4); 439-47. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28074002      PMCID: PMC5552883          DOI: 10.1158/1541-7786.MCR-16-0262

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  21 in total

1.  Metagenes and molecular pattern discovery using matrix factorization.

Authors:  Jean-Philippe Brunet; Pablo Tamayo; Todd R Golub; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

2.  In vitro fermentation of potential prebiotic flours from natural sources: impact on the human colonic microbiota and metabolome.

Authors:  Simone Maccaferri; Annett Klinder; Stefano Cacciatore; Roberto Chitarrari; Harue Honda; Claudio Luchinat; Ivano Bertini; Paola Carnevali; Glenn R Gibson; Patrizia Brigidi; Adele Costabile
Journal:  Mol Nutr Food Res       Date:  2012-07-02       Impact factor: 5.914

3.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics.

Authors:  Frank Dieterle; Alfred Ross; Götz Schlotterbeck; Hans Senn
Journal:  Anal Chem       Date:  2006-07-01       Impact factor: 6.986

4.  Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.

Authors:  D A MacIntyre; B Jiménez; E Jantus Lewintre; C Reinoso Martín; H Schäfer; C García Ballesteros; J Ramón Mayans; M Spraul; J García-Conde; A Pineda-Lucena
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

5.  Brain cholesterol homeostasis in Wilson disease.

Authors:  Stefano Cacciatore; Leonardo Tenori
Journal:  Med Hypotheses       Date:  2013-10-21       Impact factor: 1.538

6.  Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer.

Authors:  Ivano Bertini; Stefano Cacciatore; Benny V Jensen; Jakob V Schou; Julia S Johansen; Mogens Kruhøffer; Claudio Luchinat; Dorte L Nielsen; Paola Turano
Journal:  Cancer Res       Date:  2011-11-11       Impact factor: 12.701

7.  A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue.

Authors:  Min Yuan; Susanne B Breitkopf; Xuemei Yang; John M Asara
Journal:  Nat Protoc       Date:  2012-04-12       Impact factor: 13.491

8.  AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer.

Authors:  Carmen Priolo; Saumyadipta Pyne; Joshua Rose; Erzsébet Ravasz Regan; Giorgia Zadra; Cornelia Photopoulos; Stefano Cacciatore; Denise Schultz; Natalia Scaglia; Jonathan McDunn; Angelo M De Marzo; Massimo Loda
Journal:  Cancer Res       Date:  2014-10-16       Impact factor: 12.701

9.  Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.

Authors:  Nagireddy Putluri; Ali Shojaie; Vihas T Vasu; Srilatha Nalluri; Shaiju K Vareed; Vasanta Putluri; Anuradha Vivekanandan-Giri; Jeman Byun; Subramaniam Pennathur; Theodore R Sana; Steven M Fischer; Ganesh S Palapattu; Chad J Creighton; George Michailidis; Arun Sreekumar
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  KODAMA: an R package for knowledge discovery and data mining.

Authors:  Stefano Cacciatore; Leonardo Tenori; Claudio Luchinat; Phillip R Bennett; David A MacIntyre
Journal:  Bioinformatics       Date:  2017-02-15       Impact factor: 6.937

View more
  11 in total

1.  Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer.

Authors:  Kota Arima; Mai Chan Lau; Melissa Zhao; Koichiro Haruki; Jonathan A Nowak; Marios Giannakis; Charles S Fuchs; Shuji Ogino; Keisuke Kosumi; Kosuke Mima; Mancang Gu; Juha P Väyrynen; Tyler S Twombly; Yoshifumi Baba; Kenji Fujiyoshi; Junko Kishikawa; Chunguang Guo; Hideo Baba; William G Richards; Andrew T Chan; Reiko Nishihara; Jeffrey A Meyerhardt
Journal:  Mol Cancer Res       Date:  2020-03-12       Impact factor: 5.852

2.  Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging.

Authors:  Elizabeth C Randall; Giorgia Zadra; Paolo Chetta; Begona G C Lopez; Sudeepa Syamala; Sankha S Basu; Jeffrey N Agar; Massimo Loda; Clare M Tempany; Fiona M Fennessy; Nathalie Y R Agar
Journal:  Mol Cancer Res       Date:  2019-02-11       Impact factor: 5.852

Review 3.  Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

Authors:  Giorgia Zadra; Massimo Loda
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

4.  The effect of sample age on the metabolic information extracted from formalin-fixed and paraffin embedded tissue samples using desorption electrospray ionization mass spectrometry imaging.

Authors:  Olof Gerdur Isberg; Yuchen Xiang; Sigridur Klara Bodvarsdottir; Jon Gunnlaugur Jonasson; Margret Thorsteinsdottir; Zoltan Takats
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-10-28

5.  Tissue fixation effects on human retinal lipid analysis by MALDI imaging and LC-MS/MS technologies.

Authors:  Ankita Kotnala; David M G Anderson; Nathan Heath Patterson; Lee S Cantrell; Jeffrey D Messinger; Christine A Curcio; Kevin L Schey
Journal:  J Mass Spectrom       Date:  2021-12       Impact factor: 2.394

6.  Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum.

Authors:  Kathryn L Penney; Svitlana Tyekucheva; Jacob Rosenthal; Habiba El Fandy; Ryan Carelli; Stephanie Borgstein; Giorgia Zadra; Giuseppe Nicolò Fanelli; Lavinia Stefanizzi; Francesca Giunchi; Mark Pomerantz; Samuel Peisch; Hannah Coulson; Rosina Lis; Adam S Kibel; Michelangelo Fiorentino; Renato Umeton; Massimo Loda
Journal:  Mol Cancer Res       Date:  2020-11-09       Impact factor: 5.852

Review 7.  Metabolomics in cancer research and emerging applications in clinical oncology.

Authors:  Daniel R Schmidt; Rutulkumar Patel; David G Kirsch; Caroline A Lewis; Matthew G Vander Heiden; Jason W Locasale
Journal:  CA Cancer J Clin       Date:  2021-05-13       Impact factor: 286.130

Review 8.  Prostate cancer diagnosis and characterization with mass spectrometry imaging.

Authors:  Annika Kurreck; Lindsey A Vandergrift; Taylor L Fuss; Piet Habbel; Nathalie Y R Agar; Leo L Cheng
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-12-05       Impact factor: 5.554

9.  UPLC‑MS/MS‑based metabolomic characterization and comparison of pancreatic adenocarcinoma tissues using formalin‑fixed, paraffin‑embedded and optimal cutting temperature‑embedded materials.

Authors:  Di Feng; Jing Yuan; Qi Liu; Li Liu; Xu Zhang; Yali Wu; Yifan Qian; Liping Chen; Yan Shi; Mancang Gu
Journal:  Int J Oncol       Date:  2019-10-14       Impact factor: 5.650

10.  Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets.

Authors:  Dinesh Kumar Barupal; Oliver Fiehn
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.